SCHEMBL9571373

SCHEMBL9571373

O=S(=O)(Nc1cccc(CBr)c1)C(F)(F)F

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 5/20 0.56
▸ CA1 P00915 3/20 0.48
▸ PTGS1 P23219 2/20 0.47
▸ PTGS2 P35354 2/20 0.47
▸ KDM1A O60341 1/20 0.45
▸ HTR6 P50406 1/20 0.44
▸ PRMT6 Q96LA8 1/20 0.44
▸ PTPN1 P18031 1/20 0.44
▸ CYSLTR2 Q9NS75 1/20 0.43
▸ CYSLTR1 Q9Y271 1/20 0.43
▸ PTPN11 Q06124 1/20 0.42
▸ NR3C1 P04150 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ SLC6A2 P23975 1/20 0.40
▸ SLC6A4 P31645 1/20 0.40
▸ SLC6A3 Q01959 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31680271 0.84 CA2 (0.56) CA2CA1PTGS1PTGS2KDM1A
SCHEMBL19567186 0.84 PTGS1 (0.63) CA2CA1PTGS1PTGS2KDM1A
SCHEMBL21986566 0.84 CA2 (0.56) CA2CA1PTGS1PTGS2KDM1A
SCHEMBL23514767 0.81 CA2 (0.54) CA2CA1PTGS1PTGS2KDM1A
SCHEMBL20782066 0.81 CA2 (0.54) CA2CA1PTGS1PTGS2KDM1A
SCHEMBL26022134 0.80 CA2 (0.52) CA2CA1PTGS1PTGS2KDM1A
SCHEMBL9571488 0.80 PTPN1 (0.58) CA2CA1PTGS1PTGS2PTPN1
SCHEMBL29203533 0.78 NR3C1 (0.59) PTGS1HTR6NR3C1SMN1; SMN2CYP3A4
SCHEMBL30240812 0.78 NR3C1 (0.59) PTGS1HTR6NR3C1SMN1; SMN2CYP3A4
SCHEMBL7118308 0.78 CA2 (0.61) CA2CA1PTGS1PTGS2KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0546449-A2 Benzofuranderivatives as angiotensin II antagonists MERCK PATENT GmbH (DE) 1993-06-16 — — EP disclosed
Send feedback